mTOR inhibition was confirmed in the tumours by assessing the expression levels of p‐S6 in P2RY12+ CD49d− TAM‐MG and P2RY12− CD49d+ TAM‐BMDM by flow cytometry. The gene discussed is MTOR; the disease is neoplasm.